Corundum Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.15M | Sell |
|
|||||
|
2025
Q2 | $1.18M | Buy |
|
|||||
|
2025
Q1 | $1.55M | Sell |
|
|||||
|
2024
Q4 | $2.46M | Buy |
|
|||||
|
2024
Q3 | $1.34M | Sell |
|
|||||
|
2024
Q2 | $1.17M | Buy |
|
|||||
|
2024
Q1 | $570K | Buy |
|
|||||
|
2023
Q4 | $227K | Sell |
|
|||||
|
2023
Q3 | $458K | Sell |
|
|||||
|
2023
Q2 | $565K | Sell |
|
|||||
|
2023
Q1 | $1.07M | Buy |
|
|||||
|
2022
Q4 | $558K | Buy |
|
|||||
|
2022
Q3 | $523K | Buy |
|
|||||
|
2022
Q2 | $534K | Sell |
|
|||||
|
2022
Q1 | $610K | Buy |
|
|||||
|
2021
Q4 | $505K | Buy |
|
|||||
|
2021
Q3 | $428K | Buy |
|
|||||
|
2021
Q2 | $426K | Buy |
|
|||||
|
2021
Q1 | $341K | Buy |
|
|||||
|
2020
Q4 | $315K | Buy |
|
|||||
|
2020
Q3 | $295K | Buy |
|
|||||
|
2020
Q2 | $260K | Sell |
|
|||||
|
2020
Q1 | $268K | Sell |
|
|||||
|
2019
Q4 | $343K | Buy |
|
|||||
|
2019
Q3 | $262K | Sell |
|
|||||
|
2019
Q2 | $234K | Buy |
|
|||||
|
2019
Q1 | $244K | Buy |
|
|||||
|
2018
Q2 | $225K | Buy |
|
|||||
|
2018
Q1 | $245K | Sell |
|
|||||
|
2017
Q4 | $287K | Buy |
|
|||||
|
2017
Q3 | $298 | Buy |
|